Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

General Review Article

The Lord of the Bacteria: The Fellowship of the Leader and Other Serine Protease Inhibitors

Author(s): Ewa Burchacka* and Marcin Sieńczyk

Volume 24 , Issue 37 , 2018

Page: [4445 - 4465] Pages: 21

DOI: 10.2174/1381612825666181219163922

Price: $65

Abstract

Since antibiotics use is currently limited due to undesired side effects and the increasing antibiotic resistance of various bacteria strains, there is a pressing need to develop new strategies and methods preventing epidemic outbreaks.

The virulent potency of bacteria relies on a number of different extracellularly secreted factors among which proteases considered as promising, novel drug targets are of special interest. The first evidence that bacterial cysteine, serine and metalloproteinases contributed to the progression of infection was found in the early 70’s. This extracellular proteolytic system allows bacteria to penetrate into tissues, escape detection by the host’s immune mechanisms and grow despite limited access to nutrition. A molecule able to selectively inhibit the activity of bacterial proteases in the spread of infection may lead to designing novel therapeutics. Moreover, due to their mechanism of action, bacterial protease inhibitors can be used to fight antibiotic-resistant strains.

Herein, we undertake a review of various bacterial proteases together with the design and development of their inhibitors (excluding β-lactams) for the last ten years, and introduce the reader to a brief history of the subject.

Keywords: Inhibitors, bacterial serine proteases, potential antibiotics, bacteria, epidemic outbreaks, metalloproteinases.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy